Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brady

Showing results (371-380 of 627) with videos related to

Pageof 63
Sort By:
Toxicology and Applied Pharmacology|April 1, 1991
Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in ratsJ F Brady, F Xiao, M H Wang, et al.
Respiratory Care|February 19, 2025
Manual Ventilation Performance With Safety Device in Normal Versus Decreased Lung Compliance: A Single-Center Simulation StudyPrasanna Kumar, Rachel Culbreth, Douglas S Gardenhire, et al.
The Journal of Antibiotics|May 20, 2000
Biological activity of guanacastepene, a novel diterpenoid antibiotic produced by an unidentified fungus CR115M P Singh, J E Janso, S W Luckman, et al.
Clinical Dysmorphology|March 15, 2006
Mild case of Curry-Jones syndromeEllen R A Thomas, Emma L Wakeling, Frances R Goodman, et al.
Chemical Research in Toxicology|November 1, 1991
Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolitesJ F Brady, H Ishizaki, J M Fukuto, et al.
Gynecologic Oncology|August 3, 2013
Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancerRobert A Burger, Mark F Brady, Joon Rhee, et al.
Cancer|January 15, 1993
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experienceT Thigpen, M F Brady, G A Omura, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Oxydifficidin, a potent <i>Neisseria gonorrhoeae</i> antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivityJingbo Kan, Adrian Morales, Yozen Hernandez, et al.
Gynecologic Oncology|October 29, 2011
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group studyGinger J Gardner, Raymond E Baser, Mark F Brady, et al.
Autoimmunity|November 20, 2012
Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus miceAmy G Clark, Qihua Fan, Graham F Brady, et al.
Pageof 63

Showing results (371-380 of 627) with videos related to

Sort By:
Pageof 63
Toxicology and Applied Pharmacology|April 1, 1991
Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in ratsJ F Brady, F Xiao, M H Wang, et al.
Respiratory Care|February 19, 2025
Manual Ventilation Performance With Safety Device in Normal Versus Decreased Lung Compliance: A Single-Center Simulation StudyPrasanna Kumar, Rachel Culbreth, Douglas S Gardenhire, et al.
The Journal of Antibiotics|May 20, 2000
Biological activity of guanacastepene, a novel diterpenoid antibiotic produced by an unidentified fungus CR115M P Singh, J E Janso, S W Luckman, et al.
Clinical Dysmorphology|March 15, 2006
Mild case of Curry-Jones syndromeEllen R A Thomas, Emma L Wakeling, Frances R Goodman, et al.
Chemical Research in Toxicology|November 1, 1991
Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolitesJ F Brady, H Ishizaki, J M Fukuto, et al.
Gynecologic Oncology|August 3, 2013
Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancerRobert A Burger, Mark F Brady, Joon Rhee, et al.
Cancer|January 15, 1993
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experienceT Thigpen, M F Brady, G A Omura, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Oxydifficidin, a potent <i>Neisseria gonorrhoeae</i> antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivityJingbo Kan, Adrian Morales, Yozen Hernandez, et al.
Gynecologic Oncology|October 29, 2011
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group studyGinger J Gardner, Raymond E Baser, Mark F Brady, et al.
Autoimmunity|November 20, 2012
Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus miceAmy G Clark, Qihua Fan, Graham F Brady, et al.
Pageof 63